Form D · Pharmaceuticals

Cosmos Health Inc.

Chicago, IL · CIK 0001474167

Offering snapshot reported Jul 27, 2023 · SEC filing

Reported sold
$5.25M
Offering amount: $5.25M
Investors reported
3
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jul 21, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 27, 2023Initial$5,250,000No comparison3SEC filing
Jan 5, 2023Amendment$32,525,680$0vs Dec 21, 20220SEC filing
Dec 21, 2022Initial$32,525,680No comparison0SEC filing
Jun 5, 2019Initial$1,500,000No comparison1SEC filing
Sep 17, 2018Initial$2,000,000No comparison2SEC filing
Nov 29, 2017Initial$3,000,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$310K
Finders' fees
$0
Form D file number
021-488026

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
A.G.P./Alliance Global Partners8361

Source: Form D, filed Jul 27, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anastasios Aslidis Director
Demetrios G. Demetriades Director
Dimitrios Goulielmos Director
John J. Hoidas Director
Grigorios Siokas Director, Executive
Manfred Ziegler Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
141 West Jackson Blvd, Suite 4236
Chicago, IL, 60604